Scientists show drug may greatly improve cancer immunotherapy success

A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug – originally developed to tackle the scarring of organ tissue – could help to significantly improve the success rate of cancer immunotherapy treatment.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *